Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults

Ryder, S.D.
May 2003
Gut;May2003 Supplement 3, Vol. 52, p1
Academic Journal
Presents guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Categories of evidence; Grading of recommendations; Diagnosis and treatment of HCC; Non-surgical management.


Related Articles

  • Diagnosis for liver cancer.  // Newsweek;7/9/1984, Vol. 104 Issue 1, p53 

    A new test for liver cancer involves the detection in the blood of a protein called alpha-fetoprotein (AFP). The test can be done in any lab at a cost of less than $2.

  • Understanding liver cancer.  // Science Teacher;Nov97, Vol. 64 Issue 8, p12 

    Focuses on a study of pertaining to hepatitis B and C infections which causes cancer of the liver. Factors which influenced the study; Names of some of the infections which were studied; Methodology used in the study; What the findings of the study demonstrated; Comments from Randy Jirtle, lead...

  • Clinical features and prognosis of hepatocellular carcinoma in Britain in relation to age. Collier, Jane D.; Curless, Richard // Age & Ageing;Jan1994, Vol. 23 Issue 1, p22 

    Examines the clinical features and prognosis of 110 cases of hepatocellular carcinoma (HCC) from the North East of England. Incidence of HCC; Age at the time of diagnosis; Signs and symptoms at presentation; Etiology of underlying cirrhosis by age group; Markers of hepatitis B infection;...

  • Clinical and pathologic factors associated with development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study. Rosas-Camargo, Vanessa; Rodríguez-Díaz, José Luis; Vega-Vega, Olynka; Méndez-Reguera, Aniela; Espinosa, Daniela Morales; Martínez-Tlahuel, Jorge Luis; Gamboa-Domínguez, Armando; Arrieta, Oscar // BMC Cancer;2007 Supplement 1, Vol. 7, pA33 

    An abstract of the article "Clinical and pathologic factors associated with development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study," by Vanessa Rosas-Camargo, Olynka Vega-Vega, Daniela Morales Espinosa, and colleagues is presented.

  • Hepatocellular carcinoma in 48 dogs.  // Veterinary Record: Journal of the British Veterinary Association;2/12/2005, Vol. 156 Issue 7, p216 

    Presents the abstract for the article "Hepatocellular Carcinoma in 48 Dogs," by J. M. Liptak, W. S. Dernell, E. Monnett, B. E. Powers, A. M. Bachand, J. G. Kenney, and S. J. Withrow.

  • AMA specialty journal abstracts. Smith, Jeanette M. // JAMA: Journal of the American Medical Association;7/26/95, Vol. 274 Issue 4, p284d 

    Presents an abstract of the article `DNA Image Cytometric Analysis of Primary Clear Cell Carcinoma of the Liver,' by Giulia Orsatti et al published in `Archives of Pathology and Laboratory Medicine' dated 1994.

  • Liver cancer. Gravitz, Lauren // Nature;12/4/2014 Supplement, Vol. 516 Issue s7529, pS1 

    The article offers an introduction to the issue in which the editor discusses liver cancer, its diagnosis and survival rates of patients who contract it.

  • Comparative Prevalence, Multiplicity, and Progression of Spontaneous and Vinyl Carbamate-Induced Liver Lesions in Five Strains of Male Mice. Takahashi, Kimimasa; Dinse, Gregg E.; Foley, Julie F.; Hardisty, Jerry F.; Maronpot, Robert R. // Toxicologic Pathology;Sep/Oct2002, Vol. 30 Issue 5, p599 

    The overall and age-specific prevalences and multiplicities of spontaneous and chemically induced hepatocellular neoplasia were compared among male B6D2F1, B6C3F1, C3H (C3H/HeNCrl MTV-), B6CF1, and C57BL/6 (C57BL/6NCrl) mice following a single intraperitoneal injection of 0.03 μM vinyl...

  • Therapeutic Strategies for Hepatitis B virus-Associated Hepatocellular Carcinoma. Ee-Tsin Wong; Yat-Peng Chew; Linda A. Lee; Caroline G.L. Lee // Current Drug Targets;Oct2002, Vol. 3 Issue 5, p369 

    Hepatocellular carcinoma (HCC) is a one of the most prevalent cancers worldwide, especially in the Asia Pacific region. At present, the five-year survival of individuals with HCC is low, mainly due to the late presentation of the disease, and limited therapeutic options. The major risk factors...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics